In a report released today, Arun Viswanathan from RBC Capital maintained a Buy rating on Chemours Company (CC – Research Report), with a price target of $48.00. The company’s shares closed last Tuesday at $38.91, close to its 52-week high of $39.20.
According to TipRanks.com, Viswanathan is a 5-star analyst with an average return of 7.3% and a 58.9% success rate. Viswanathan covers the Basic Materials sector, focusing on stocks such as Sherwin-Williams Company, Axalta Coating Systems, and Ardagh Metal Packaging.
Currently, the analyst consensus on Chemours Company is a Moderate Buy with an average price target of $41.33, implying a 15.4% upside from current levels. In a report issued on May 2, Alembic Global also maintained a Buy rating on the stock with a $40.00 price target.
Chemours Company’s market cap is currently $6.2B and has a P/E ratio of 10.75.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.
Read More on CC: